Back to Search
Start Over
Beyond BRCA1/2: Clinician-reported utility 3 years post panel testing
- Source :
- Journal of Clinical Oncology. 36:e18705-e18705
- Publication Year :
- 2018
- Publisher :
- American Society of Clinical Oncology (ASCO), 2018.
-
Abstract
- e18705Background: Germline testing guidelines are centered on BRCA1 and BRCA2 despite clear medical management recommendations in several other high and moderate penetrance genes. Clinician utiliza...
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 36
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........f63dfee931a10ef82c1fbe719bd8d505
- Full Text :
- https://doi.org/10.1200/jco.2018.36.15_suppl.e18705